IFN-γ directly inhibits murine B-cell precursor leukemia-initiating cell proliferation early in life. (Q40293619)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

title

IFN-γ directly inhibits murine B-cell precursor leukemia-initiating cell proliferation early in life (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Nina Rolf

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Laura M Sly

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Gregor S Reid

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

7

Stephan A Grupp

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

author name string

Mario Fidanza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Sumin Jo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

Amina Kariminia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

language of work or name

English

0 references

publication date

11 April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

5 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

page(s)

892-899

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia

5 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Mechanisms of pre-B-cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

In utero rearrangements in the trithorax-related oncogene in infant leukaemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Infection, immune responses and the aetiology of childhood leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Incidence of common preleukemic gene fusions in umbilical cord blood in Slovak population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Daycare attendance and risk of childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Ethnic difference in daycare attendance, early infections, and risk of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Day-care, early common infections and childhood acute leukaemia: a multicentre French case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Day care in infancy and risk of childhood acute lymphoblastic leukaemia: findings from UK case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

A meta-analysis of the association between day-care attendance and childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Early life exposure to infections and risk of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Childhood acute lymphoblastic leukemia and indicators of early immune stimulation: a Childhood Leukemia International Consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Childhood acute lymphoblastic leukaemia and indicators of early immune stimulation: the Estelle study (SFCE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Exposure to infections and risk of leukemia in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Perspectives on the causes of childhood leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

TGFβ and IL10 have an impact on risk group and prognosis in childhood ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Profound deficit of IL10 at birth in children who develop childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Modulation of IL-7 thresholds by SOCS proteins in developing B lineage cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

The many roles of IL-7 in B cell development; mediator of survival, proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

IL-7 in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Ikaros is absolutely required for pre-B cell differentiation by attenuating IL-7 signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Increased risk of ALL among premature infants is not explained by increased prevalence of pre-leukemic cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Suppression of lymphoma and epithelial malignancies effected by interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited Susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

7 January 2021

Prenatal origin of acute lymphoblastic leukaemia in children

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

7 January 2021

Immunosurveillance of childhood ALL: polymorphic interferon-gamma alleles are associated with age at diagnosis and clinical risk groups

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

7 January 2021

Gene expression analysis reveals a strong signature of an interferon-induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

7 January 2021

Role of interferon-gamma in immune cell regulation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201646806

7 January 2021

Identifiers

DOI

10.1002/EJI.201646806

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28295300%20AND%20SRC:MED&resulttype=core&format=json

5 April 2020

1 reference